干旱区生态环境知识资源中心(Arid): Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)

Arid

	Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)
	Meyer, Joos; Fry, Carly; Turner, Angus; Razavi, Hessom
来源期刊	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
ISSN	1442-6404
EISSN	1442-9071
出版年	2022
卷号	49 期号:8 页码:829-830
类型	Meeting Abstract
语种	英语
收录类别	SCI-E
WOS记录号	WOS:000721587100035
WOS类目	Ophthalmology
WOS研究方向	Ophthalmology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/374531
作者单位	[Meyer, Joos; Fry, Carly; Turner, Angus; Razavi, Hessom] Lions Eye Inst, Perth, Australia; [Meyer, Joos; Razavi, Hessom] Lions Outback Vis, Broome, Australia; [Turner, Angus] Lions Outback Vis, Perth, WA, Australia; [Turner, Angus; Razavi, Hessom] Univ Western Australia, Ctr Ophthalmol & Vis Sci, Perth, WA, Australia
推荐引用方式 GB/T 7714	Meyer, Joos,Fry, Carly,Turner, Angus,et al. Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)[J],2022,49(8):829-830.
APA	Meyer, Joos,Fry, Carly,Turner, Angus,&Razavi, Hessom.(2022).Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial).CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY,49(8),829-830.
MLA	Meyer, Joos,et al."Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)".CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 49.8(2022):829-830.